Study of the Immunogenicity and Efficacy of HBsAg Vaccine in combination with standard antiviral therapy in patients who have been treated with HB110E Hepatitis B DNA vaccine

Trial Profile

Study of the Immunogenicity and Efficacy of HBsAg Vaccine in combination with standard antiviral therapy in patients who have been treated with HB110E Hepatitis B DNA vaccine

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Jun 2014

At a glance

  • Drugs GX 110 (Primary) ; Entecavir
  • Indications Hepatitis B
  • Focus Pharmacodynamics
  • Sponsors Genexine
  • Most Recent Events

    • 03 Jan 2014 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov. record
    • 20 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 08 May 2013 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea: KCT0000713)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top